Infliximab for ulcerative colitis.
Shields
Conor J
CJ
Winter
Desmond C
DC
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D039021:Colonic Pouches / Q000009:adverse effects; D005242:Fecal Incontinence / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D011788:Quality of Life; D012074:Remission Induction; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab